North America Contract Research Organization (CRO) Market to 2025 - Regional Analysis and Forecasts by Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, Post-Approval Services); End User (Pharmaceutical & Biotechnology Companies and Medical Device Companies) and Country
Publication Month: Apr 2019
Report Code: TIPRE00004300 No. of Pages: 150 Category: Pharmaceuticals Status: Published
The North America contract research organization (CRO) market is expected to reach US$ 30.7 Bn in 2025 from US$ 16.3 Bn in 2017. The market is estimated to grow with a CAGR of 8.4% from 2018-2025.
The growth of the market is driven by the factors such as, increasing R&D expenditures and outsourcing activities and rise in the number of clinical trials. However, the market is likely to get impacted due to dearth of skilled professionals and regional competition in the CRO services market, in the region.
Pharmaceutical and biotech companies are focusing on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$ 49.6 Bn 2012 to US$ 58.8 Bn in 2015. Research and development expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch. According to the International Federation of Pharmaceutical Manufacturers & Associations, the R&D expenditures in 2014 by the pharmaceuticals and biotechnology industry grew by approximately 8.7% than that of the expenditures in 2013. Moreover, in United States, investments for R&D by pharmaceutical companies had grown consistently over the last 15 years. The intensity for R&D by the companies in Japan accounted for about 13.3%, in US it accounted approximately 17% and in the European Union it was registered to be approximately 13% in the year 2014. Therefore, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) in order to save the cost and time which is expected to drive the growth of the market.
US is expected to lead the market in the North America region owing to increasing expenditure of research and development expenditures in the country. The confrontation of biotechnology and pharmaceutical companies to lower the drug development costs is expected to propel the CROs market in the US. Moreover, the presence of top revenue generating pharmaceutical companies in the US that have capability to invest a large amount in R&D is also expected to boost the growth of CROs in the US. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
Exhibit: Mexico Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) – MARKET SEGMENTATION
By Type
- Clinical Research Services
- Early Phase Development Services
- Laboratory Services
- Post-Approval Services
By End User
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
By Geography
• North America
- US
- Canada
- Mexico
Company Profiles
- IQVIA
- Laboratory Corporation of America Holdings
- PAREXEL International Corporation
- ICON plc
- Syneos Health
- PRA Health Sciences
- Charles River
- Pharmaceutical Product Development, LLC
- WuXi AppTec
- Medpace
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. North America CONTRACT RESEARCH ORGANIZATION (CRO) Market – Key takeaways
PART 3. North America contract research organization (CRO) market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Contract Research Organization (CRO) Market – By Type
3.2.2 North America Contract Research Organization (CRO) Market – By End User
3.2.3 North America Contract Research Organization (CRO) Market – By Country
3.3 PEST Analysis
PART 4. North America contract research organization (CRO) market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing R&D Expenditures and Outsourcing Activities
4.1.2 Rise in The Number of Clinical Trials
4.2 Key Market Restraints
4.2.1 Dearth Of Skilled Professionals
4.2.2 Regional Competition in The CRO Services Market
4.3 Key Market Opportunities
4.3.1 Growing Biosimilars and Biologics Market
4.3.2 Increasing Demand for Specialized Testing Services
4.4 future Trends
4.4.1 Increasing Market Consolidation
4.5 Impact analysis
PART 5. Contract Research Organization (CRO) market – North America Analysis
5.1 North America CONTRACT RESEARCH ORGANIZATION (CRO) market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.4 expert opinions
PART 6. North America CONTRACT RESEARCH ORGANIZATION (CRO) market Analysis – By Type
6.1 Overview
6.2 North America contract research organization (CRO) MARKET, BY Type 2017 & 2025 (%)
6.3 North America CONTRACT RESEARCH ORGANIZATION (CRO) market Revenue And Forecasts to 2025, By type (US$ Mn)
6.4 early phase development services Market
6.4.1 Overview
6.4.2 North America Early Phase Development Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.4.3 Drug Discovery Services
6.4.3.1 Overview
6.4.3.2 North America Drug Discovery Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.4.4 Pre-Clinical Services
6.4.4.1 Overview
6.4.4.2 North America Pre-Clinical Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 Clinical research services
6.5.1 Overview
6.5.2 North America Clinical Research Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 Laboratory services
6.6.1 Overview
6.6.2 North America Laboratory Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 post-approval services
6.7.1 Overview
6.7.2 North America Post-Approval Services Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. North America contract research organization (CRO) market Analysis – By End User
7.1 Overview
7.2 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY end user, 2017 & 2025 (%)
7.3 North America CONTRACT RESEARCH ORGANIZATION (CRO) market Revenue And Forecasts to 2025, By end user (US$ Mn)
7.4 Pharmaceutical and biotechnology companies
7.4.1 Overview
7.4.2 North America Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 medical device companies
7.5.1 Overview
7.5.2 North America Medical Device Companies Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. North America contract research organization (CRO) market Revenue and Forecasts to 2025
8.1 Overview
8.2 North America contract research organization (CRO) Market Revenue and Forecasts to 2025 (us$ Mn)
8.2.1 North America Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.2.1.1 North America Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.2.2 North America Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.3 North America contract research organization (CRO) Market share, By Country (2017 & 2025) (%)
8.4 Us contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.4.1 US Contract Research Organization (CRO) Market revenue And Forecasts to 2025 (US$ Mn)
8.4.2 US Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.4.2.1 US Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.4.3 US Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.5 canada contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.5.1 Canada Contract Research organization (CRO) Market Revenue And Forecasts to 2025 (US$ Mn)
8.5.2 Canada Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.5.2.1 Canada Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.5.3 Canada Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.6 mexico contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.1 Mexico Contract Research Organization (CRO) Market Revenue And Forecasts to 2025 (US$ Mn)
8.6.2 Mexico Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.6.2.1 Mexico Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
8.6.3 Mexico Contract Research Organization (CRO) Market Revenue And Forecasts to 2025, By End User (US$ Mn)
PART 9. CONTRACT RESEARCH ORGANIZATION (CRO) Market –Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Contract research organization (CRO) Market, 2015-2018
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.3.2 Merger & Acquisitions
9.3.3 Collaborations
9.3.4 Partnership
9.3.5 Alliance
9.3.6 Agreement & Joint Venture
9.4 Organic Growth Strategies
9.4.1 Overview
9.4.2 Launch
9.4.3 Expansion & Relocation
9.4.4 Enhancements
PART 10. contract research organization (CRO) Market – Key company profiles
10.1 IQVIA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Information
10.1.4 Service Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 PAREXEL International Corporation
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Service Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Syneos Health
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Information
10.3.4 Service Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Laboratory Corporation of America Holdings
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Service Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 PRA Health Sciences, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Service Portfolio
10.5.5 Swot Analysis
10.5.6 Key Developments
10.6 Charles River
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Service Portfolio
10.6.5 Swot Analysis
10.6.6 Key Developments
10.7 ICON plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Service Portfolio
10.7.5 Swot Analysis
10.7.6 Key Developments
10.8 Pharmaceutical Product Development, LLC.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Service Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 WuXi AppTec
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Service Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Medpace
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
list of tables
TABLE 1. R&D Investments by major pharmaceutical companies
TABLE 2. R&D Investments by Phrma member companies,2016
TABLE 3. Number of resgistered studies for Clinical Trials
TABLE 4. Rank of global CROs, in 2016
TABLE 5. Consolidation across the cro industry
TABLE 6. North America CONTRACT RESEARCH ORGANIZATION (CRO) market Revenue And Forecasts to 2025, By type (US$ Mn)
TABLE 7. North America CONTRACT RESEARCH ORGANIZATION (CRO) market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 8. north america Contract research organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 9. North America Early phase development services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 10. North America Contract research organization (CRO) Market Revenue And Forecasts to 2025, By end user (US$Mn)
TABLE 11. US: R&D investments by pharmaceutical companies, (2015-2016)
TABLE 12. US Contract research organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 13. US Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 14. US Contract research organization (CRO) Market Revenue And Forecasts to 2025, By end user (US$Mn)
TABLE 15. Canada Contract research organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 16. Canada Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 17. Canada Contract research organization (CRO) Market Revenue And Forecasts to 2025, By end user (US$Mn)
TABLE 18. Mexico Contract research organization (CRO) Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 19. Mexico Early Phase Development Services Market Revenue And Forecasts to 2025, By Type (US$ Mn)
TABLE 20. Mexico Contract research organization (CRO) Market Revenue And Forecasts to 2025, By end user (US$Mn)
TABLE 21. Recent Merger & Acquisitions in the Contract research organization (CRO) market
TABLE 22. Recent Collaborations in the Contract research organization (CRO) market
TABLE 23. Recent partnerships in the Contract research organization (CRO) market
TABLE 24. Recent alliances in the Contract research organization (CRO) market
TABLE 25. Recent agreement & joint venture in the Contract research organization (CRO) market
TABLE 26. Recent Launches in the Contract research organization (CRO) Market
TABLE 27. Recent EXPANSIONS & relocation in the Contract research organization (CRO) Market
TABLE 28. enhancements in the Contract research organization (CRO) Market
TABLE 29. Glossary of Terms, CONTRACT RESEARCH ORGANIZATION (CRO) market
list of figures
FIGURE 1. US contract research organization (CRO) market, Revenue (US$ Mn), By COuntry 2018 & 2025
FIGURE 2. North America Contract research organization (CRO) Market By type, Market Share (%), 2017
FIGURE 3. North America Contract research organization (CRO) Market By END user, Market Share (%), 2017
FIGURE 4. contract research organization (CRO) market Segmentation
FIGURE 5. North America PEST Analysis
FIGURE 6. Number of approvals for NDA & BLA (2005 to 2016)
FIGURE 7. contract research organization (CRO) market impact analysis of drivers & Restraints
FIGURE 8. North America CONTRACT RESEARCH ORGANIZATION (CRO) market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 9. North America contract research organization (CRO) Market breakdown, by Type 2017 & 2025 (%)
FIGURE 10. North America Early Phase Services Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 11. North America Drug Discovery Services Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 12. North America Pre-Clinical Trial Services Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. North America Clinical research services Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. North America laboratory services Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. North America post-approval services Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. North America CONTRACT RESEARCH ORGANIZATION (CRO) market By end user, 2017 & 2025 (%)
FIGURE 17. North America Pharmaceutical and biotechnology companies Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 18. North America medical device companies Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. North America contract research organization (CRO) market REVENUE overview, by Country, 2017 (US$ MN)
FIGURE 20. north america contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. North America contract research organization (CRO) Market share, By Country (2017 & 2025) (%)
FIGURE 22. US contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Canada contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 24. Mexico contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 25. Growth Strategies in the Contract research organization (CRO) Market, 2015-2018
FIGURE 26. Inorganic Growth Strategies in the Contract research organization (CRO) Market, 2015-2018
FIGURE 27. Organic Growth Strategies in the Contract research organization (CRO) Market, 2015-2018
The List of Companies
- IQVIA
- Laboratory Corporation of America Holdings
- PAREXEL International Corporation
- ICON plc
- Syneos Health
- PRA Health Sciences
- Charles River
- Pharmaceutical Product Development, LLC
- WuXi AppTec
- Medpace